STOCK TITAN

[Form 4] Curtiss-Wright Corp. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

The Form 4 filing discloses that Curtiss-Wright Corp. (CW) Vice President & CFO K. Christopher Farkas acquired 30 shares of common stock on July 2, 2025 through the company’s Employee Stock Purchase Plan (ESPP). The purchase was coded “A” (acquisition) and is exempt under Rule 16b-3. The effective purchase price was $414.23 per share, reflecting the ESPP’s 15% discount to the average market price on June 30, 2025. Following the transaction, Farkas directly owns 9,283 shares of CW common stock. No derivative securities were reported, and there were no dispositions. The filing represents a routine, small-scale increase in insider ownership rather than a strategic shift.

Il modulo Form 4 rivela che K. Christopher Farkas, Vice Presidente e CFO di Curtiss-Wright Corp. (CW), ha acquisito 30 azioni ordinarie il 2 luglio 2025 tramite il Piano di Acquisto Azionario per Dipendenti (ESPP) della società. L'acquisto è stato classificato come “A” (acquisizione) ed è esente ai sensi della Regola 16b-3. Il prezzo effettivo di acquisto è stato di 414,23 $ per azione, riflettendo lo sconto del 15% previsto dall’ESPP rispetto al prezzo medio di mercato del 30 giugno 2025. Dopo questa operazione, Farkas detiene direttamente 9.283 azioni ordinarie di CW. Non sono stati segnalati titoli derivati né disposizioni. La comunicazione rappresenta un aumento di proprietà interna di piccola entità e di routine, non un cambiamento strategico.

La presentación del Formulario 4 revela que K. Christopher Farkas, Vicepresidente y CFO de Curtiss-Wright Corp. (CW), adquirió 30 acciones ordinarias el 2 de julio de 2025 a través del Plan de Compra de Acciones para Empleados (ESPP) de la empresa. La compra fue clasificada como “A” (adquisición) y está exenta bajo la Regla 16b-3. El precio efectivo de compra fue de $414.23 por acción, reflejando el descuento del 15% del ESPP sobre el precio promedio de mercado al 30 de junio de 2025. Tras la transacción, Farkas posee directamente 9,283 acciones ordinarias de CW. No se reportaron valores derivados ni disposiciones. La presentación representa un aumento rutinario y pequeño en la propiedad interna, no un cambio estratégico.

Form 4 제출서에 따르면 Curtiss-Wright Corp.(CW)의 부사장 겸 CFO인 K. Christopher Farkas가 2025년 7월 2일 회사의 직원 주식 구매 계획(ESPP)을 통해 보통주 30주를 취득했습니다. 이 거래는 “A”(취득)로 분류되었으며 Rule 16b-3에 따라 면제됩니다. 실제 매입 가격은 주당 414.23달러로, 2025년 6월 30일 평균 시장 가격에서 ESPP의 15% 할인율이 반영된 금액입니다. 거래 후 Farkas는 CW 보통주 9,283주를 직접 보유하고 있습니다. 파생 증권은 보고되지 않았으며, 처분도 없었습니다. 이 제출은 전략적 변화가 아닌 일상적이고 소규모의 내부자 지분 증가를 나타냅니다.

Le dépôt du Formulaire 4 révèle que K. Christopher Farkas, Vice-président et CFO de Curtiss-Wright Corp. (CW), a acquis 30 actions ordinaires le 2 juillet 2025 via le Plan d’Achat d’Actions des Employés (ESPP) de la société. L’achat a été codé « A » (acquisition) et est exempté en vertu de la Règle 16b-3. Le prix d’achat effectif était de 414,23 $ par action, reflétant la remise de 15 % de l’ESPP par rapport au prix moyen du marché au 30 juin 2025. Après cette transaction, Farkas détient directement 9 283 actions ordinaires de CW. Aucun titre dérivé n’a été déclaré et aucune cession n’a eu lieu. Ce dépôt représente une augmentation de participation interne de faible ampleur et de routine, plutôt qu’un changement stratégique.

Die Form 4-Einreichung zeigt, dass K. Christopher Farkas, Vice President und CFO von Curtiss-Wright Corp. (CW), am 2. Juli 2025 30 Stammaktien über den Employee Stock Purchase Plan (ESPP) des Unternehmens erworben hat. Der Kauf wurde als „A“ (Erwerb) codiert und ist gemäß Regel 16b-3 ausgenommen. Der effektive Kaufpreis betrug 414,23 $ pro Aktie, was dem 15%igen Rabatt des ESPP auf den durchschnittlichen Marktpreis vom 30. Juni 2025 entspricht. Nach der Transaktion besitzt Farkas direkt 9.283 Aktien der CW-Stammaktien. Es wurden keine Derivate gemeldet und keine Veräußerungen getätigt. Die Einreichung stellt eine routinemäßige, geringfügige Erhöhung der Insider-Beteiligung dar und keinen strategischen Wechsel.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Minor ESPP buy; neutral governance signal.

The CFO’s purchase of 30 shares, worth roughly US$12,400, is immaterial relative to Curtiss-Wright’s market capitalization and to his existing 9,283-share stake. Because the acquisition was executed via the ESPP, it reflects automatic payroll deductions rather than discretionary buying. Such routine purchases generally carry limited informational value for investors and do not suggest a change in management’s outlook or insider sentiment. I classify the impact on shareholder perception and valuation as neutral.

Il modulo Form 4 rivela che K. Christopher Farkas, Vice Presidente e CFO di Curtiss-Wright Corp. (CW), ha acquisito 30 azioni ordinarie il 2 luglio 2025 tramite il Piano di Acquisto Azionario per Dipendenti (ESPP) della società. L'acquisto è stato classificato come “A” (acquisizione) ed è esente ai sensi della Regola 16b-3. Il prezzo effettivo di acquisto è stato di 414,23 $ per azione, riflettendo lo sconto del 15% previsto dall’ESPP rispetto al prezzo medio di mercato del 30 giugno 2025. Dopo questa operazione, Farkas detiene direttamente 9.283 azioni ordinarie di CW. Non sono stati segnalati titoli derivati né disposizioni. La comunicazione rappresenta un aumento di proprietà interna di piccola entità e di routine, non un cambiamento strategico.

La presentación del Formulario 4 revela que K. Christopher Farkas, Vicepresidente y CFO de Curtiss-Wright Corp. (CW), adquirió 30 acciones ordinarias el 2 de julio de 2025 a través del Plan de Compra de Acciones para Empleados (ESPP) de la empresa. La compra fue clasificada como “A” (adquisición) y está exenta bajo la Regla 16b-3. El precio efectivo de compra fue de $414.23 por acción, reflejando el descuento del 15% del ESPP sobre el precio promedio de mercado al 30 de junio de 2025. Tras la transacción, Farkas posee directamente 9,283 acciones ordinarias de CW. No se reportaron valores derivados ni disposiciones. La presentación representa un aumento rutinario y pequeño en la propiedad interna, no un cambio estratégico.

Form 4 제출서에 따르면 Curtiss-Wright Corp.(CW)의 부사장 겸 CFO인 K. Christopher Farkas가 2025년 7월 2일 회사의 직원 주식 구매 계획(ESPP)을 통해 보통주 30주를 취득했습니다. 이 거래는 “A”(취득)로 분류되었으며 Rule 16b-3에 따라 면제됩니다. 실제 매입 가격은 주당 414.23달러로, 2025년 6월 30일 평균 시장 가격에서 ESPP의 15% 할인율이 반영된 금액입니다. 거래 후 Farkas는 CW 보통주 9,283주를 직접 보유하고 있습니다. 파생 증권은 보고되지 않았으며, 처분도 없었습니다. 이 제출은 전략적 변화가 아닌 일상적이고 소규모의 내부자 지분 증가를 나타냅니다.

Le dépôt du Formulaire 4 révèle que K. Christopher Farkas, Vice-président et CFO de Curtiss-Wright Corp. (CW), a acquis 30 actions ordinaires le 2 juillet 2025 via le Plan d’Achat d’Actions des Employés (ESPP) de la société. L’achat a été codé « A » (acquisition) et est exempté en vertu de la Règle 16b-3. Le prix d’achat effectif était de 414,23 $ par action, reflétant la remise de 15 % de l’ESPP par rapport au prix moyen du marché au 30 juin 2025. Après cette transaction, Farkas détient directement 9 283 actions ordinaires de CW. Aucun titre dérivé n’a été déclaré et aucune cession n’a eu lieu. Ce dépôt représente une augmentation de participation interne de faible ampleur et de routine, plutôt qu’un changement stratégique.

Die Form 4-Einreichung zeigt, dass K. Christopher Farkas, Vice President und CFO von Curtiss-Wright Corp. (CW), am 2. Juli 2025 30 Stammaktien über den Employee Stock Purchase Plan (ESPP) des Unternehmens erworben hat. Der Kauf wurde als „A“ (Erwerb) codiert und ist gemäß Regel 16b-3 ausgenommen. Der effektive Kaufpreis betrug 414,23 $ pro Aktie, was dem 15%igen Rabatt des ESPP auf den durchschnittlichen Marktpreis vom 30. Juni 2025 entspricht. Nach der Transaktion besitzt Farkas direkt 9.283 Aktien der CW-Stammaktien. Es wurden keine Derivate gemeldet und keine Veräußerungen getätigt. Die Einreichung stellt eine routinemäßige, geringfügige Erhöhung der Insider-Beteiligung dar und keinen strategischen Wechsel.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Bamford Lynn M

(Last) (First) (Middle)
C/O CURTISS-WRIGHT CORPORATION
130 HARBOUR PLACE DRIVE

(Street)
DAVIDSON NC 28036

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CURTISS WRIGHT CORP [ CW ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chair and CEO
3. Date of Earliest Transaction (Month/Day/Year)
07/02/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/02/2025 A(1) 26 A $414.23(2) 42,913 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Shares were acquired pursuant to the Issuer's Employee Stock Purchase Plan ("ESPP"), under which the Reporting Person agrees to payroll deductions prior to the commencement of a six-month offering period whereby the payroll deductions are accumulated for the purchase of shares at the end of the offering period. This transaction is exempt under both Rule 16b-3(d) and Rule 16b-3(c).
2. In accordance with the terms of the ESPP, the purchase price is calculated by giving a 15% discount on the average selling price of the Issuer's common stock price on June 30, 2025, the last day of the offering period.
Remarks:
George P. McDonald by Power of Attorney from Lynn M. Bamford 07/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did CW's CFO report on Form 4?

K. Christopher Farkas acquired 30 CW common shares through the Employee Stock Purchase Plan.

When did the Curtiss-Wright (CW) insider purchase occur?

The transaction date listed is July 2, 2025.

What was the purchase price in the Curtiss-Wright ESPP transaction?

The effective price was $414.23 per share, reflecting a 15% ESPP discount.

How many CW shares does the CFO own after the transaction?

After the purchase, Farkas directly owns 9,283 CW shares.

Was the acquisition discretionary or part of a plan?

It was automatic under the Employee Stock Purchase Plan and exempt under Rule 16b-3.
Curtiss Wright Corp

NYSE:CW

CW Rankings

CW Latest News

CW Latest SEC Filings

CW Stock Data

18.20B
37.48M
0.66%
87.12%
1.17%
Aerospace & Defense
Misc Industrial & Commercial Machinery & Equipment
Link
United States
DAVIDSON